Duchenne muscular dystrophy classification: Difference between revisions

Jump to navigation Jump to search
Fahimeh Shojaei (talk | contribs)
No edit summary
Fahimeh Shojaei (talk | contribs)
No edit summary
Line 21: Line 21:
|-
|-
! style="background: #DCDCDC; text-align: center;" |Stage 3
! style="background: #DCDCDC; text-align: center;" |Stage 3
| style="background: #F5F5F5;" |
| style="background: #F5F5F5;" |Can only walk short distances with walker or crutch
|-
|-
! style="background: #DCDCDC; text-align: center;" |Stage 4
! style="background: #DCDCDC; text-align: center;" |Stage 4
| style="background: #F5F5F5;" |
| style="background: #F5F5F5;" |Unable to walk but they can use powered mobility devices
|-
|-
! style="background: #DCDCDC; text-align: center;" |Stage5
! style="background: #DCDCDC; text-align: center;" |Stage5
| style="background: #F5F5F5;" |
| style="background: #F5F5F5;" |unable to walk, unable to use powered devices
|}
|}
==References==
==References==

Revision as of 14:11, 29 April 2019

Duchenne muscular dystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Duchenne muscular dystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Duchenne muscular dystrophy classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Duchenne muscular dystrophy classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Duchenne muscular dystrophy classification

CDC on Duchenne muscular dystrophy classification

Duchenne muscular dystrophy classification in the news

Blogs on Duchenne muscular dystrophy classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Duchenne muscular dystrophy classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

Classification

There is no established system for the classification of Duchenne muscular dystrophy but according to the Functional Classification System for DMD (AFCSD), there are 5 sungroups of Duchenne muscular dystrophy based on the gross Motor Function.

Stages Explanation
Stage 1 Walks normally without any help
Stage 2 Impaired posture (lordosis), Impaired gait (tip-toeing or waddling), still doesn't need any assistive device and walks independently
Stage 3 Can only walk short distances with walker or crutch
Stage 4 Unable to walk but they can use powered mobility devices
Stage5 unable to walk, unable to use powered devices

References

Template:WH Template:WS